Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Apr. 2, 2025 Chinese
Research progress of empagliflozin in the treatment of type 2 diabetes mellitus and cardiovascular and renal benefits
LIU Zihan, DU Wenyu, GUO Caihui, WANG Zhi, LI Ying, DONG Zhanjun
Chinese Journal of Clinical Pharmacology and Therapeutics . 2025, (3): 412 -418 .  DOI: 10.12092/j.issn.1009-2501.2025.03.015